Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction
Publication
, Conference
Krasuski, RA; Whitney, EJ; Kolasa, M; Personius, BJ; Brown, BG; Gotto, AM
Published in: CIRCULATION
October 26, 2004
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
819 / 820
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Krasuski, R. A., Whitney, E. J., Kolasa, M., Personius, B. J., Brown, B. G., & Gotto, A. M. (2004). Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction. In CIRCULATION (Vol. 110, pp. 819–820). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Krasuski, R. A., E. J. Whitney, M. Kolasa, B. J. Personius, B. G. Brown, and A. M. Gotto. “Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction.” In CIRCULATION, 110:819–20. LIPPINCOTT WILLIAMS & WILKINS, 2004.
Krasuski RA, Whitney EJ, Kolasa M, Personius BJ, Brown BG, Gotto AM. Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 819–20.
Krasuski, R. A., et al. “Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction.” CIRCULATION, vol. 110, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2004, pp. 819–20.
Krasuski RA, Whitney EJ, Kolasa M, Personius BJ, Brown BG, Gotto AM. Combination therapy with gemfibrozil, niacin, and cholestyramine reduces the prevalence of metabolic syndrome above and beyond aggressive lifestyle modification and dietary restriction. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 819–820.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
819 / 820
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology